Dilidesk
A startup trust workspace that converts approved system facts and policies into reviewable data flows, subprocessors, questionnaire candidates, AI disclosures and a versioned evidence export.
Startups selling into enterprise repeatedly answer security, privacy and AI-use questions before they can afford a full governance platform. Dilidesk gathers a bounded system inventory and approved policies, then drafts a buyer-facing trust packet whose claims cite their source. The supplied research confirms a direct questionnaire-and-evidence competitor, an open governance platform and a document generator for one European regime. Those subscriptions and audit services are observed market references, not fixed product pricing. The supported wedge is one-pass packet assembly for a nontechnical founder; it is modest and copyable. A pasted description is an assertion, not evidence. System component, data flow, subprocessor, policy statement, questionnaire answer, reviewer approval, buyer delivery, buyer acceptance, independent audit and compliance outcome remain separate. Missing policies, unknown subprocessors and contradictory descriptions stay visible. The product can reduce repetitive drafting and preserve versions. It cannot certify security, privacy or legal compliance, invent controls, conduct an independent audit, mark a questionnaire true without an accountable owner or call an export audit-ready merely because it is formatted.
A startup security, privacy or operations owner responding to enterprise vendor diligence with named control and legal reviewers.
Founders want instant answers, while buyers need accurate, sourced and accountable representations.
Current compliance tooling interest and active European rules support a good window.
No cross-references or inbound connections provide weak convergence.
A concrete startup diligence workflow, several validated adjacent products and a bounded source-linked packet make a useful quick product.
The moat is modest, direct competition exists and customer facts, legal review and evidence quality limit automation.
Discussion
No comments yet — be the first to weigh in.
